Ethyl 2-(1-azidocyclohexyl)acetate

• 分子结构分类: 有机化合物 - 有机1,3-偶极化合物 - 烯丙基型1,3-偶极有机化合物
• 英文名称: Ethyl 2-(1-azidocyclohexyl)acetate
• 英文别名: ethyl 2-(1-azidocyclohexyl)acetate
• 化学式: C10H17N3O2
• 分子量: 211.26
• InChiKey: LYVNZAISYGESIV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.9
• 拓扑面积：
  40.7
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease
  申请人：Pfizer Inc.

  公开号：US20040220186A1

  公开（公告）日：2004-11-04

  The invention provides compounds of Formula (I) 1 the stereoisomers and prodrugs thereof, and the pharmaceutically acceptable salts of the compounds, stereoisomers, and prodrugs, wherein A, P, J, x, and R 10 are as defined herein; pharmaceutical compositions thereof; and methods of using the pharmaceutical compositions for the treatment of diseases, including, diabetes, including type 1 and type 2 diabetes, hyperglycemia, dyslipidemia, impaired glucose tolerance, metabolic syndrome, and/or cardiovascular disease.

  该发明提供了公式（I）1的化合物及其立体异构体和前药，以及该化合物、立体异构体和前药的药学上可接受的盐，其中A、P、J、x和R10如本文所定义；其制药组合物；以及使用该制药组合物治疗疾病的方法，包括糖尿病，包括1型和2型糖尿病，高血糖，血脂异常，葡萄糖耐量受损，代谢综合征和/或心血管疾病。
• [EN] PDE9 INHIBITORS FOR TREATING TYPE 2 DIABETES, METABOKIC SYNDROME, AND CARDIOVASCULAR DISEASE<br/>[FR] INHIBITEURS DE PDE9 POUR LE TRAITEMENT DU DIABETE DE TYPE 2, DU SYNDROME METABOLIQUE ET DE MALADIES CARDIO-VASCULAIRES
  申请人：PFIZER PROD INC

  公开号：WO2004096811A1

  公开（公告）日：2004-11-11

  The invention provides compounds of Formula (I) the stereoisomers and prod rugs thereof, and the pharmaceutically acceptable salts of the compounds, stereoisomers, and prodrugs, wherein A, P, J, x, and R10 are as defined herein; pharmaceutical compositions thereof; and methods of using the pharmaceutical compositions for the treatment of diseases, including, diabetes, including type 1 and type 2 diabetes, hyperglycemia, dyslipidemia, impaired glucose tolerance, metabolic syndrome, and/or cardiovascular disease.